Guest Editorial: Innovation will be a bridge to cure in patients with multiple myeloma?

Int J Hematol. 2022 Jun;115(6):760-761. doi: 10.1007/s12185-022-03371-3. Epub 2022 May 11.

Author

Hiroyuki Takamatsu¹

Affiliation

¹ Department of Hematology, Kanazawa University Hospital/School of Entrepreneurial and Innovation Studies, Institute of Transdisciplinary Sciences for Innovation, Kanazawa University, 13-1 Takaramachi, Kanazawa, 920-8641, Japan. takamaz@staff.kanazawa-u.ac.jp.

PMID: 35543898
DOI: 10.1007/s12185-022-03371-3

No abstract available

Publication types

Editorial

MeSH terms

Humans
Multiple Myeloma* / therapy